Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 4/20 | 0.53 |
| ▸ | MMP2 | P08253 | 4/20 | 0.53 |
| ▸ | MMP3 | P08254 | 4/20 | 0.53 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.48 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.48 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.43 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.43 |
| ▸ | NMT1 | P30419 | 6/20 | 0.41 |
| ▸ | NMT2 | O60551 | 5/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | OXTR | P30559 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7205806 | 0.80 | MMP1 (0.58) | MMP1MMP2MMP3CHRNB2CHRNB4 | |
| Hydrochloric Acid SCHEMBL7205132 | 0.79 | MMP1 (0.57) | MMP1MMP2MMP3CPB2LTA4H | |
| SCHEMBL26904745 | 0.79 | CHRNB2 (0.55) | MMP1MMP2MMP3CHRNB2CHRNB4 | |
| SCHEMBL26080390 | 0.78 | GNPAT (0.44) | ITGB3ITGA2BPTPN1EPHX2 | |
| SCHEMBL24158323 | 0.78 | HPGD (0.47) | MMP1MMP2MMP3ITGB3ITGA2B | |
| SCHEMBL31181255 | 0.75 | ITGB3 (0.49) | MMP1MMP2MMP3ITGB3ITGA2B | |
| SCHEMBL3667923 | 0.75 | ITGB3 (0.87) | MMP1MMP2MMP3ITGB3ITGA2B | |
| SCHEMBL26427747 | 0.74 | EPHX2 (0.42) | ITGB3ITGA2BCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL23921469 | 0.74 | PSEN1 (0.46) | MMP1MMP2MMP3 | |
| SCHEMBL31181293 | 0.73 | ITGB3 (0.50) | MMP1MMP2MMP3ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11566058-B2 | Process for the preparation of high purity glucagon | Fresenius Kabl iPSUM S.R.L. (IT) | 2023-01-31 | — | — | US | disclosed |
| US-20200399339-A1 | PROCESS FOR THE PREPARATION OF HIGH PURITY GLUCAGON | Fresenius Kabi Ipsum S.R.L. (IT) | 2020-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11566058-B2 | Process for the preparation of high purity glucagon | IAPP, GCG, GLP1R | MMP1 4773/4885MMP2 2648/4885MMP3 4121/4885 |
| US-20200399339-A1 | PROCESS FOR THE PREPARATION OF HIGH PURITY GLUCAGON | IAPP, GCG, GLP1R | MMP1 4773/4885MMP2 2648/4885MMP3 4121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.